Digital Therapeutics for Neurological Disorders Market Fueled by Smartphone-Based Cognitive Therapies 2025-2033 | Akili, Inc., Click Therapeutics, Inc., BigHealth, Apple Inc.

Global Digital Therapeutics for Neurological Disorders Market reached US$ 246.94 million in 2024 and is expected to reach US$ 504.36 million by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.

The latest Digital Therapeutics for Neurological Disorders market research report from DataM Intelligence delivers a comprehensive analysis of the global Digital Therapeutics for Neurological DisordersMarket landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. By leveraging advanced analytics, technology trend mapping, and regulatory assessment, the report highlights emerging growth drivers, evolving care models, and investment opportunities. It equips stakeholders with strategic intelligence essential for navigating the complex healthcare ecosystem from clinical innovation to operational efficiency across the forecast period 2024-2031.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/digital-therapeutics-for-neurological-disorders-market?ophp

Digital therapeutics are evidence-based, software-driven treatments designed to manage or treat neurological conditions like ADHD and epilepsy. The market is expanding as healthcare providers and patients seek non-pharmacological, accessible solutions through mobile and digital platforms.

Comprehensive Insight into Digital Therapeutics for Neurological Disorders Market Competitor Landscape:

Akili, Inc., Click Therapeutics, Inc., BigHealth, Apple Inc., MindMaze Inc, NeuroPace, Inc., NeurologyToolKit, Matoph Labs e.U., Fullpower Technologies, Inc., Neybox Digital Ltd. and among others.

Important Mergers, Acquisitions, and Market Shifts:

✅ Supernus Pharmaceuticals acquires Sage Therapeutics (June 2025): Supernus agreed to acquire Sage for $561M upfront, with up to $795M including milestones. Sage's AI-enhanced Zurzuvae for postpartum depression and pipeline for Parkinson's and Alzheimer's bolster Supernus's neuro-focused offerings

✅ AbbVie acquires Aliada Therapeutics (late 2024-closed Q1 2025): While announced earlier, the $1.4B deal bolsters AbbVie's neurology pipeline with an Alzheimer's-targeted antibody crossing the blood-brain barrier

✅ Draig Therapeutics raises $140M Series A (June 2025): This Welsh biotech secured funding to advance its oral treatment (DT‐101) for severe depression and other neuro disorders into Phase II, leveraging MEG-based biomarkers

✅ AI-powered VR neuro-rehabilitation tools debut (Arab Health 2025, Jan): Virtual‐reality-based therapies for Parkinson's, gait, and cognitive improvement are gaining traction, supported by AI platforms showcased at major global conferences

✅ AI-enhanced seizure detection system "SeizureTransformer" published (April 2025): This transformer‐based model improves long EEG data analysis for epilepsy, achieving top accuracy in a 2025 challenge-paving the way for real-time clinical DTx tools

Market Drivers:

The increasing prevalence of neurological disorders like anxiety, depression, and ADHD, along with the acceptance of clinically validated digital interventions, is propelling market growth.

Digital Therapeutics for Neurological Disorders Market Segments

By Product Type (Software Therapeutics and Wearable Devices)
By Disease Type (Neurodegenerative Disorders, Mental Health Disorders, Stroke & Cerebrovascular Disorders, Sleep Disorders, Cognitive Disorders and others)
By End-User (Hospitals, Specialty Clinics, Neuro-Rehabilitation Centers, Homecare Settings and Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-therapeutics-for-neurological-disorders-market?ophp

Methodology and Scope:

This Digital Therapeutics for Neurological Disorders Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Digital Therapeutics for Neurological Disorders Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-for-neurological-disorders-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Digital Therapeutics for Neurological Disorders market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Digital Therapeutics for Neurological Disorders industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Digital Therapeutics for Neurological Disorders market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.